住院医师诊疗连续性对医疗并发症与住院时长的影响:Medicare参保住院患者分析
暴露为住院第1至3天提交收费的不同住院医师数量:49.6%为同一医师,44.5%为2名,6.0%为3名。主要终点住院时长及第4天及以后ICU转入或药物毒性新诊断。结果显示多名住院医师与住院时长或后续ICU转入无显著关联,但2名或3名医师接诊者药物毒性新诊断的校正比值比轻微升高(2名:OR 1.04,95%CI 1.02-1.07;3名:OR 1.07,95%CI 1.03-1.12)。结论认为,对于全程由住院医师提供一般医疗的患者,多名住院医师接诊与更差结局的关联证据有限。
要点
- 前3天由同一住院医师接诊者占49.6%,2名者占44.5%,3名者占6.0%。
- 多名住院医师接诊与住院时长或第4天及以后ICU转入无显著关联。
- 2名或3名住院医师接诊者药物毒性新诊断的校正OR分别为1.04(95%CI 1.02-1.07)和1.07(95%CI 1.03-1.12)。
- 结论认为,对于全程由住院医师提供一般医疗的患者,多名住院医师接诊与更差结局的关联证据有限。
适用人群与场景
- 2016至2018年Medicare医疗入院索赔数据中住院时长超过4天的患者。
- 排除住院第1至3天同日有多次住院医师收费或入住ICU的入院。
- 患者平均年龄80.2岁(SD 8.4),58.7%为女性。
诊断标准与关键阈值
- 原文未提及
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 暴露为住院第1至3天提交收费的不同住院医师数量:同一医师49.6%,2名44.5%,3名6.0%。
- 主要终点为总住院时长及第4天或以后转入ICU或新诊断药物毒性。
- 多名住院医师与住院时长或后续ICU转入无显著关联。
- 2名住院医师接诊者药物毒性新诊断校正OR 1.04(95%CI 1.02-1.07),3名者OR 1.07(95%CI 1.03-1.12)。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:观察性设计,仅纳入住院超过4天且排除前3天ICU入住或同日多次收费者,使用行政索赔数据,可能存在混杂和编码偏倚。
对床旁实践的改变
- 对于全程由住院医师提供一般医疗的患者,前3天由多名住院医师接诊与住院时长或后续ICU转入无显著关联,不应仅基于医师数量预测这些结局。
- 多名住院医师接诊与药物毒性新诊断风险轻微升高相关(OR 1.04-1.07),提示交接时需关注用药安全,但原文未提供具体干预措施。
- 研究排除前3天入住ICU或同日多次收费的入院,结论不适用于这些人群。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Continuity in primary care is associated with improved outcomes, but less information is available on the association of continuity of care in the hospital with hospital complications.
OBJECTIVE: To assess whether the number of hospitalists providing care is associated with subsequent hospital complications and length of stay.
DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study used multilevel logistic regression models to analyze Medicare claims for medical admissions from 2016 to 2018 with a length of stay longer than 4 days. Admissions with multiple charges on the same day from a hospitalist or an intensive care unit (ICU) stay during hospital days 1 to 3 were excluded. The data were accessed and analyzed from November 1, 2020, to April 30, 2021.
EXPOSURES: The number of different hospitalists who submitted charges during hospital days 1 to 3.
MAIN OUTCOMES AND MEASURES: Overall length of stay and transfer to ICU or a new diagnosis of drug toxic effects on hospital day 4 or later.
RESULTS: Among the 617 680 admissions, 362 376 (58.7%) were women, with a mean (SD) age of 80.2 (8.4) years. In 306 037 admissions (49.6%), the same hospitalist provided care on days 1 to 3, while 2 hospitalists provided care in 274 658 admissions (44.5%), and 3 hospitalists provided care in 36 985 admissions (6.0%). There was no significant association between the number of different hospitalists on days 1 to 3 and either length of stay or subsequent ICU transfers. Admissions seeing 2 or 3 hospitalists had a slightly greater adjusted odds of subsequent new diagnoses of drug toxic effects (2 hospitalists: odds ratio [OR], 1.04; 95% CI, 1.02-1.07; 3 hospitalists: OR, 1.07; 95% CI, 1.03-1.12).
CONCLUSIONS AND RELEVANCE: There was little evidence that receiving care from multiple hospitalists was associated with worse outcomes for patients receiving all their general medical care from hospitalists.
参考来源
- Goodwin JS, Li S, Hommel E, et al. Association of Inpatient Continuity of Care With Complications and Length of Stay Among Hospitalized Medicare Enrollees. JAMA Netw Open. 2021. PMID: 34383060. doi:10.1001/jamanetworkopen.2021.20622
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。